308.79 0.00 (0.00%)
After hours: 4:49PM EDT
|Bid||301.29 x 800|
|Ask||317.45 x 800|
|Day's Range||308.41 - 319.27|
|52 Week Range||225.82 - 372.61|
|Beta (3Y Monthly)||1.40|
|PE Ratio (TTM)||55.54|
|Earnings Date||Apr 22, 2019 - Apr 26, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||339.93|
Healthcare, blockchain, data privacy, and community all converge in an innovative new company that should be on your radar. See what LunaDNA's cofounder says about the future of consumer genomics.
Illumina Inc NASDAQ/NGS:ILMNView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for ILMN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative but appears to be improving. Over the last one-month, outflows of investor capital in ETFs holding ILMN totaled $4.82 billion. However, outflows appear to be slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
In December 2018, Illumina, Inc. (NASDAQ:ILMN) released its most recent earnings announcement, which indicated that the business benefited from a robust tailwind, eventuating to a double-digit earnings growth of 14%.Read More...
With Alani Nutrition being a women-focused supplement brand, it is believed that the partnership might help GNC Holdings (GNC) widen its customer base.
March 7 (Reuters) - Boai NKY Medical Ltd: * SAYS IT SIGNS COOPERATION AGREEMENT WITH ILLUMINA Source text in Chinese: https://bit.ly/2IYYNZu Further company coverage: (Reporting by Hong Kong newsroom)
Synergies from Alere consolidation in the form of revenues from Abbott's (ABT) Rapid Diagnostics business have been driving growth.
Illumina, Inc. (ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. The live webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentation will be posted on Illumina’s web site after the event and will be available for at least 30 days following.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Investors pursuing a solid, dependable stock investment can often beRead More...
Where Druckenmiller Suggests Investing amid Market Fluctuation(Continued from Prior Part)Druckenmiller’s top buysIn this article, we’ll discuss Stanley Druckenmiller’s top buys in the fourth quarter. Druckenmiller seemed to be positive on